MANH
Manhattan Associates, Inc. [MANH] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
MANH Stock Summary
Top MANH Correlated Resources
MANH
Top 10 Correlated ETFs
MANH
Top 10 Correlated Stocks
MANH
In the News
Here's Why Manhattan Associates (MANH) is a Great Momentum Stock to Buy
Does Manhattan Associates (MANH) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Must-Buy Nasdaq Listed Technology Stocks to Tap the Rally
We have narrowed our search to five Nasdaq Composite listed technology stocks that have rallied more than 20% year to date. These are: META, FTNT, NVDA, CRWD and MANH.
3 Soaring Stocks Set to Move Higher
A solid earnings report and encouraging estimate revisions trend generally send shares higher.
Top 5 Momentum Stocks for May Amid Fed's FOMC Meeting
We have narrowed our search to five momentum stocks that have popped in the past month with more upside left. These are: META, DHI, WSO, PHM and MANH.
New Strong Buy Stocks for April 27th
SAND, ASC, SIGA, WSO and MANH have been added to the Zacks Rank #1 (Strong Buy) List on April 27, 2023.
Why Manhattan Associates Stock Popped 10% Today
Manhattan Associates beat earnings handily in its Q1 report released last night. Forward guidance, however, suggests a dramatic slowdown in growth may be in the cards for 2023.
Manhattan Associates, Inc. (MANH) Q1 2023 Earnings Call Transcript
Manhattan Associates, Inc. (MANH) Q1 2023 Earnings Call Transcript.
Manhattan Associates (MANH) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Manhattan Associates (MANH) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Manhattan Associates (MANH) Q1 Earnings and Revenues Top Estimates
Manhattan Associates (MANH) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.60 per share a year ago.
Manhattan Associates Announces Date for Reporting First Quarter 2023 Financial Results
ATLANTA--(BUSINESS WIRE)--Manhattan Associates Inc. (NASDAQ: MANH) today announced it will release its first quarter 2023 financial results on Tuesday, April 25, 2023, after the stock market closes. The press release will be followed by a conference call hosted by Manhattan Associates senior management at 4:30 p.m. Eastern time, also on April 25.
MANH Financial details
MANH Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 8.45 | 9.6 | 9.23 | 10.46 | 12.22 | |
| Net income per share | 1.58 | 1.33 | 1.37 | 1.74 | 2.05 | |
| Operating cash flow per share | 2.07 | 2.28 | 2.22 | 2.92 | 2.86 | |
| Free cash flow per share | 1.96 | 2.05 | 2.17 | 2.86 | 2.76 | |
| Cash per share | 1.52 | 1.72 | 3.22 | 4.16 | 3.59 | |
| Book value per share | 2.22 | 2.21 | 3.45 | 3.95 | 3.61 | |
| Tangible book value per share | 1.28 | 1.24 | 2.47 | 2.97 | 2.62 | |
| Share holders equity per share | 2.22 | 2.21 | 3.45 | 3.95 | 3.61 | |
| Interest debt per share | 0 | 0.52 | 0.45 | 0.37 | 0.23 | |
| Market cap | 2.8B | 5.14B | 6.68B | 9.87B | 7.62B | |
| Enterprise value | 2.71B | 5.06B | 6.51B | 9.62B | 7.41B | |
| P/E ratio | 26.79 | 59.88 | 76.6 | 89.3 | 59.09 | |
| Price to sales ratio | 5.02 | 8.31 | 11.4 | 14.87 | 9.93 | |
| POCF ratio | 20.42 | 34.96 | 47.44 | 53.27 | 42.42 | |
| PFCF ratio | 21.57 | 38.99 | 48.37 | 54.45 | 44.04 | |
| P/B Ratio | 19.06 | 36.1 | 30.53 | 39.36 | 33.6 | |
| PTB ratio | 19.06 | 36.1 | 30.53 | 39.36 | 33.6 | |
| EV to sales | 4.84 | 8.18 | 11.1 | 14.5 | 9.66 | |
| Enterprise value over EBITDA | 18.68 | 40.49 | 52.72 | 67.54 | 47.9 | |
| EV to operating cash flow | 19.7 | 34.43 | 46.18 | 51.97 | 41.24 | |
| EV to free cash flow | 20.81 | 38.4 | 47.09 | 53.13 | 42.81 | |
| Earnings yield | 0.04 | 0.02 | 0.01 | 0.01 | 0.02 | |
| Free cash flow yield | 0.05 | 0.03 | 0.02 | 0.02 | 0.02 | |
| Debt to equity | 1.09 | 1.62 | 1.13 | 1.15 | 1.51 | |
| Debt to assets | 0.52 | 0.62 | 0.53 | 0.54 | 0.6 | |
| Net debt to EBITDA | -0.68 | -0.63 | -1.43 | -1.69 | -1.37 | |
| Current ratio | 1.48 | 1.28 | 1.7 | 1.64 | 1.32 | |
| Interest coverage | 0 | 137.84 | 167.24 | 265.48 | 256.21 | |
| Income quality | 1.31 | 1.71 | 1.61 | 1.68 | 1.39 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.09 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Research and developement to revenue | 0.13 | 0.14 | 0.14 | 0.15 | 0.15 | |
| Intangibles to total assets | 0.2 | 0.17 | 0.13 | 0.12 | 0.11 | |
| Capex to operating cash flow | -0.05 | -0.1 | -0.02 | -0.02 | -0.04 | |
| Capex to revenue | -0.01 | -0.02 | 0 | -0.01 | -0.01 | |
| Capex to depreciation | -0.85 | -1.9 | -0.31 | -0.51 | -0.99 | |
| Stock based compensation to revenue | 0.04 | 0.05 | 0.06 | 0.07 | 0.08 | |
| Graham number | 8.89 | 8.14 | 10.32 | 12.44 | 12.92 | |
| ROIC | 1.13 | 0.66 | 2.29 | -15.1 | 1.33 | |
| Return on tangible assets | 0.43 | 0.28 | 0.22 | 0.23 | 0.25 | |
| Graham Net | 0.25 | -0.68 | 0.63 | 1.07 | 0.11 | |
| Working capital | 70.12M | 50.45M | 137.06M | 159.38M | 99.78M | |
| Tangible asset value | 84.91M | 80.04M | 156.65M | 188.41M | 164.57M | |
| Net current asset value | 55.38M | 2.04M | 87.53M | 119.36M | 72M | |
| Invested capital | 0 | 0.23 | 0.13 | 0.09 | 0.06 | |
| Average receivables | 96.55M | 100.91M | 105.07M | 116.81M | 145.59M | |
| Average payables | 16.1M | 19.37M | 19.18M | 18.72M | 22.66M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 65.85 | 59.62 | 67.98 | 68.43 | 79.35 | |
| Days payables outstanding | 27.55 | 26.34 | 24.08 | 24.05 | 26.19 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 5.54 | 6.12 | 5.37 | 5.33 | 4.6 | |
| Payables turnover | 13.25 | 13.86 | 15.16 | 15.18 | 13.94 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.71 | 0.6 | 0.4 | 0.44 | 0.57 | |
| Capex per share | -0.11 | -0.24 | -0.04 | -0.06 | -0.1 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
| Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 2.83 | 3.05 | 3.16 | 3.18 | 3.55 | |
| Net income per share | 0.48 | 0.49 | 0.47 | 0.61 | 0.62 | |
| Operating cash flow per share | 0.5 | 0.84 | 0.64 | 0.89 | 0.94 | |
| Free cash flow per share | 0.48 | 0.82 | 0.61 | 0.85 | 0.93 | |
| Cash per share | 3.42 | 3.4 | 3.15 | 3.62 | 2.92 | |
| Book value per share | 3.43 | 3.32 | 3.17 | 3.64 | 2.91 | |
| Tangible book value per share | 2.45 | 2.33 | 2.17 | 2.64 | 1.91 | |
| Share holders equity per share | 3.43 | 3.32 | 3.17 | 3.64 | 2.91 | |
| Interest debt per share | 0.34 | 0.3 | 0.28 | 0.23 | 0.22 | |
| Market cap | 8.77B | 7.21B | 8.33B | 7.57B | 9.63B | |
| Enterprise value | 8.57B | 7.02B | 8.15B | 7.36B | 9.46B | |
| P/E ratio | 71.65 | 58.51 | 70.15 | 49.95 | 62.09 | |
| Price to sales ratio | 49 | 37.59 | 42.03 | 38.19 | 43.59 | |
| POCF ratio | 275.8 | 136.92 | 208.58 | 137 | 164.07 | |
| PFCF ratio | 286.24 | 139.8 | 219.06 | 143.32 | 165.95 | |
| P/B Ratio | 40.38 | 34.56 | 42.03 | 33.36 | 53.2 | |
| PTB ratio | 40.38 | 34.56 | 42.03 | 33.36 | 53.2 | |
| EV to sales | 47.91 | 36.58 | 41.12 | 37.13 | 42.82 | |
| Enterprise value over EBITDA | 244.89 | 190.01 | 220.99 | 160.39 | 191.67 | |
| EV to operating cash flow | 269.67 | 133.23 | 204.08 | 133.18 | 161.2 | |
| EV to free cash flow | 279.87 | 136.02 | 214.33 | 139.32 | 163.05 | |
| Earnings yield | 0 | 0 | 0 | 0.01 | 0 | |
| Free cash flow yield | 0 | 0.01 | 0 | 0.01 | 0.01 | |
| Debt to equity | 1.36 | 1.46 | 1.6 | 1.51 | 1.93 | |
| Debt to assets | 0.58 | 0.59 | 0.62 | 0.6 | 0.66 | |
| Net debt to EBITDA | -5.57 | -5.27 | -4.88 | -4.61 | -3.41 | |
| Current ratio | 1.47 | 1.38 | 1.29 | 1.32 | 1.15 | |
| Interest coverage | 1.79K | 404.92 | 328.3 | 119.85 | 70.59 | |
| Income quality | 1.04 | 1.71 | 1.35 | 1.46 | 1.51 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.1 | 0.1 | 0.09 | 0.09 | 0.09 | |
| Research and developement to revenue | 0.15 | 0.15 | 0.15 | 0.14 | 0.14 | |
| Intangibles to total assets | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 | |
| Capex to operating cash flow | -0.04 | -0.02 | -0.05 | -0.04 | -0.01 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | 0 | |
| Capex to depreciation | -0.66 | -0.62 | -1.15 | -1.62 | -0.45 | |
| Stock based compensation to revenue | 0.08 | 0.08 | 0.07 | 0.08 | 0.08 | |
| Graham number | 6.12 | 6.04 | 5.81 | 7.05 | 6.39 | |
| ROIC | 0.55 | 0.47 | 0.3 | 0.4 | 0.27 | |
| Return on tangible assets | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | |
| Graham Net | 0.33 | 0.14 | -0.19 | 0.11 | -0.77 | |
| Working capital | 120.22M | 103.33M | 82.73M | 99.78M | 48.75M | |
| Tangible asset value | 154.9M | 146.51M | 135.92M | 164.57M | 118.84M | |
| Net current asset value | 82.65M | 69M | 50.11M | 72M | 21.73M | |
| Invested capital | 0.1 | 0.09 | 0.09 | 0.06 | 0.07 | |
| Average receivables | 128.23M | 132.95M | 138.68M | 155.14M | 163.67M | |
| Average payables | 22.11M | 24.87M | 26.26M | 26.53M | 25.53M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 66.4 | 62.77 | 65.2 | 75.76 | 65.39 | |
| Days payables outstanding | 26.52 | 25.54 | 25.61 | 25.7 | 22.02 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 1.36 | 1.43 | 1.38 | 1.19 | 1.38 | |
| Payables turnover | 3.39 | 3.52 | 3.51 | 3.5 | 4.09 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.14 | 0.15 | 0.15 | 0.17 | 0.21 | |
| Capex per share | -0.02 | -0.02 | -0.03 | -0.04 | -0.01 |
MANH Frequently Asked Questions
What is Manhattan Associates, Inc. stock symbol ?
Manhattan Associates, Inc. is a US stock , located in Atlanta of Ga and trading under the symbol MANH
Is Manhattan Associates, Inc. buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $157.5. The lowest prediction is $150 and the highest is $165
What is MANH stock prediction ?
What is Manhattan Associates, Inc. stock quote today ?
Manhattan Associates, Inc. stock price is $185.775 today.
Is Manhattan Associates, Inc. stock public?
Yes, Manhattan Associates, Inc. is a publicly traded company.
Company Profile
- Volume Average 292.82K
- Market Capitalization 11.5B
- Employee 4.34K
- CEO Mr. Eddie Capel
- Headquarters Atlanta,GA,US
- IPO Date 1998-04-23
-
Website
https://www.manh.com 
Manhattan Associates, Inc. develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations. It offers Manhattan SCALE, a portfolio of logistics execution solutions that provide trading partner management, yard management, optimization, warehouse management, and transportation execution services; and Manhattan Active, a set of enterprise and store omni-channel solutions. The company also provides inventory optimization, planning, and allocation solutions; maintenance services comprising customer support services and software enhancements; professional services, such as solutions planning and implementation, and related consulting services; and training and change management services. In addition, it resells computer hardware, radio frequency terminal networks, radio frequency identification chip readers, bar code printers and scanners, and other peripherals. The company offers products through direct sales personnel, as well as through partnership agreements with various organizations. It serves grocery, food and beverage, manufacturing, medical and pharmaceutical, retail, third-party logistics, and wholesale industries. The company operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Manhattan Associates, Inc. was founded in 1990 and is headquartered in Atlanta, Georgia.
